Blue Ocean Capital Group
Overview
Blue Ocean Capital Group (BOCG) is a venture capital firm focusing on life sciences investments, including biotechnology, medical devices, and health technology. The firm operates in Greater China, the United States, and Northern Europe, aiming to drive innovation and transformation in the healthcare sector. BOCG's investment strategy emphasizes supporting innovative biotech and medical device companies at various stages, from early to late-stage development. The firm leverages its extensive industry experience and global network to empower portfolio companies, facilitating their growth and success. As a signatory to the United Nations-supported Principles for Responsible Investment (UN PRI), BOCG is committed to promoting responsible investment practices and sustainable development within the life sciences industry. This commitment reflects the firm's dedication to integrating environmental, social, and governance factors into its investment decisions, ensuring positive impacts for both companies and society.
Investment Focus
- Innovative biotech and medical device companies
- Strong growth potential
- Alignment with ESG principles
Portfolio Companies
Reach Blue Ocean Capital Group directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Blue Ocean Capital Group
What sectors does Blue Ocean Capital Group invest in?
Blue Ocean Capital Group invests in HealthTech, Medical Devices and Biotechnology, and is based in Guangdong, China. Blue Ocean Capital Group is listed as a venture capital in the ConnectSafely investor database.
What stage does Blue Ocean Capital Group invest at?
Blue Ocean Capital Group backs companies at Early Stage, Growth and Late Stage, writing cheques of 10M - 50M.
Which regions does Blue Ocean Capital Group invest in?
Blue Ocean Capital Group invests across United States, Europe, China and Sweden.
What companies has Blue Ocean Capital Group invested in?
Blue Ocean Capital Group's portfolio includes Boan Biotech, HighTide Therapeutics, Ribo Life Science, Innorna, Signet Therapeutics, Koka Lifesciences and R Plus Health.
Last updated · Source: ConnectSafely investor database
